Gregory W. Smith
Impact in
-
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- Protein Degradation and Inhibitors
-
- Nanoparticle-Based Drug Delivery
Papers in
- Surgery 2
- Testicular diseases and treatments 1
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
- Co-authors
- Harry A. Drabkin (2 shared papers)Jonathan E. Rosenberg (1 shared paper)Toni K. Choueiri (1 shared paper)Andrea Harzstark (2 shared papers)Levi A. Garraway (1 shared paper)Primo N. Lara (1 shared paper)Damian A. Laber (2 shared papers)Robert A. Figlin (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Pharmacotherapy (1 paper)Urology (1 paper)Cancer (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesSingaporeTanzania
In The Last Decade
Gregory W. Smith
11 papers receiving 494 citations
Gregory W. Smith's Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 303
- Biomaterials 34
- Oncology 50
- Cancer Research 27
- Surfaces, Coatings and Films 13
Countries citing papers authored by Gregory W. Smith
This map shows the geographic impact of Gregory W. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory W. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory W. Smith more than expected).
Fields of papers citing papers by Gregory W. Smith
This network shows the impact of papers produced by Gregory W. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory W. Smith. The network helps show where Gregory W. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory W. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma Hit paper breakdown → | 2013 | 345 |
| 2 | 1990 | 58 | |
| 3 | 1984 | 43 | |
| 4 | 2003 | 23 | |
| 5 | 2010 | 15 | |
| 6 | 2000 | 12 | |
| 7 | 2010 | 7 | |
| 8 | 2017 | 4 | |
| 9 | 1983 | 3 | |
| 10 | 1993 | 2 | |
| 11 | 1988 | 1 | |
| 12 | 2011 | 0 |
About Gregory W. Smith
Gregory W. Smith is a scholar working on Molecular Biology, Surgery, Sociology and Political Science, Pulmonary and Respiratory Medicine and Oncology, having authored 12 papers that have together received 513 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Testicular diseases and treatments (1 paper), Semiconductor materials and devices (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Renal cell carcinoma treatment (1 paper), Marine animal studies overview (1 paper), Gallbladder and Bile Duct Disorders (1 paper) and Marine and fisheries research (1 paper). The work is most often cited by research in Molecular Biology (303 citations), Biomaterials (34 citations), Oncology (50 citations), Cancer Research (27 citations) and Surfaces, Coatings and Films (13 citations). Gregory W. Smith has collaborated with scholars based in United States, Singapore and Tanzania. Frequent co-authors include Harry A. Drabkin, Jonathan E. Rosenberg, Toni K. Choueiri, Andrea Harzstark, Levi A. Garraway, Primo N. Lara, Damian A. Laber, Robert A. Figlin, Nikhil Wagle and Richard Bambury. Their work appears in journals such as Journal of Clinical Oncology, Annals of Pharmacotherapy, Urology, Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.